BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 880803)

  • 1. The effect of various steroids on corpus luteum function.
    Hooley RD; Williams DM; Findlay JK
    Contraception; 1977 Jan; 15(1):53-64. PubMed ID: 880803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reaction of contraceptive steroids in competitive binding assays of progesterone and estradiol.
    Kharma K; Stone S; Thorneycroft IH; Nakamura RM; Mishell DR
    Am J Obstet Gynecol; 1972 Mar; 112(5):676-80. PubMed ID: 4110418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of the assays for progesterone and estradiol in saliva in family planning research].
    Zheng SH; Wang HZ; Shen WX; Sun ZD; Gao SM
    Shengzhi Yu Biyun; 1987; 7(1):35-8. PubMed ID: 12341308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of continuous daily administration of 0.03 mg of d-norgestrel on the plasma levels of progesterone and the urinary excretion of oestrogens.
    Larsson-Cohn U; Johansson ED; Gemzell C
    Acta Endocrinol (Copenh); 1971 Apr; 66(4):702-10. PubMed ID: 5108098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose progestagens as contraceptive agents.
    Elstein M
    IPPF Med Bull; 1970; 4(1):2-4. PubMed ID: 12255089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 17alpha-ethinyl-19-nortestosterone (ENT) on corpus luteum function.
    Lehmann F; Just-Nastansky I; Czygan PJ; Bettendorf G
    Eur J Obstet Gynecol Reprod Biol; 1976; 6(4):219-22. PubMed ID: 987942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of nor-ethisterone enanthate on the structure of ovary, particularly corpus luteum.
    Aghari K
    J Obstet Gynaecol India; 1970 Jun; 20(3):393-6. PubMed ID: 12275253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on sustained contraceptive effects with subcutaneous polydimethylsiloxane implants. 2. Maintenance of ovarian function in patients with megestrol acetate implants.
    Benagiano G; Ermini M; Carenza L; Donini P
    Acta Endocrinol (Copenh); 1973 Jun; 73(2):347-59. PubMed ID: 4740834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical mucus in estrous ewes after treatment with estrogen, progestogens and intrauterine devices.
    Rexroad CE; Barb CR
    J Anim Sci; 1977 Jan; 44(1):102-5. PubMed ID: 64467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of indomethacin on estrogen-induced luteolysis in the ewe.
    Lewis PE; Warren JE
    Prostaglandins; 1977 May; 13(5):957-63. PubMed ID: 866703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium.
    Ling WY; Wrixon W; Zayid I; Acorn T; Popat R; Wilson E
    Fertil Steril; 1983 Mar; 39(3):292-7. PubMed ID: 6402387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of various progestational preparations on gonadotropin secretion in ovariectomized immature female rats.
    McPherson JC; Costoff A; Eldridge JC; Mahesh VB
    Fertil Steril; 1974 Dec; 25(12):1063-70. PubMed ID: 4430386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma progesterone levels during long-term treatment with levonorgestrel silastic implants.
    Croxatto HB; Diaz S; Pavez M; Miranda P; Brandeis A
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):307-11. PubMed ID: 6814139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prostaglandins on the in vitro steroidogenesis in human ovarian tissues.
    Patwardhan VV; Lanthier A
    Prostaglandins; 1974 Jun; 6(5):385-8. PubMed ID: 4851688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of synthetic gestagens on progesterone formation in vitro in human corpus luteum of pregnancy.
    Karjalainen O; Saure A; Teravainen T
    ICRS J Int Res Commun; 1974 Jan; 2(1):1017. PubMed ID: 4430395
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
    J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.